Everything currently sold as sermorelin is compounded (through 503A/503B pharmacies) or research-grade, which is not the same as an approved, GMP-manufactured, batch-tested drug
The Summary of Product Characteristics for Mounjaro (tirzepatide) explains that tirzepatide has the potential to impact the rate of absorption of concomitantly administered oral medicinal products and that the impact is most pronounced at the time of tirzepatide treatment initiation. The tirzepatide Patient Information Leaflet advises that if you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine. While Ozempic and Wegovy contain semaglutide and work by mimicking a hormone called GLP-1 that triggers an increase in the production of insulin, Mounjaro contains the active ingredient tirzepatide, and also acts on a second hormone involved in appetite and blood sugar control
Common side effects may include: Nausea Vomiting Lower appetite Early feelings of fullness GLP-1 drugs for weight management and blood sugar control may lead to low blood sugar levels (hypoglycemia)
If fasting insulin rose significantly, discuss with a healthcare provider you may need to adjust protocol or add insulin-sensitizing strategies
[6] Tirzepatide (Mounjaro): up to 15 mg once weekly for type 2 diabetes, and up to 15 mg once weekly for chronic weight management (marketed as Tirzepatide)
Keep a side-by-side record of diet, exercise, and sleep so that any differences are easier to interpret